↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

321 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   ABX-464  0件:   -   -   -   3件:
46,
96,
97
 2   AC-430  0件:   -   -   -   1件:
46
 3   ADL5859  1件: Adl5859;   -   -   -   1件:
46
 4   AMG 108  1件: Amg 108;   -   -   -   1件:
46
 5   AZD-5672  0件:   -   -   -   1件:
46
 6   AZD-9056  0件:   -   -   -   2件:
46,
96
 7   Abatacept  27件: Abatacept; Abatacept injection; Bms 188667 (abatacept); Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept (bms-188667); Abatacept (iv); Abatacept + csdmard; Abatacept + methotrexate; Abatacept + vaccines; Abatacept placebo; Abatacept prefilled syringe; Abatacept, rituximab or tocilizumab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Decrease tocilizumab, abatacept; Double-blind abatacept; Intravenous (iv) abatacept; Iv abatacept; Open-label abatacept; Orencia (abatacept); Orencia abatacept; Subcutaneous (sc) abatacept; Subcutaneous abatacept; Subcutaneous(sc) abatacept; Tocilizumab, abatacept; Abatacept subcutaneous; Abatacept sc; Abatacept (aba);   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300
 8   Acalabrutinib  1件: Acalabrutinib;   D10893   -   -   1件:
46
 9   Aceclofenac  1件: Aceclofenac;   D01545   3件: PTGES, PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
46
 10   Acetaminophen  8件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen/paracetamol; Acetaminophen tablets; Paracetamol (acetaminophen); Tramadol hydrochloride + acetaminophen; Oxycodone/acetaminophen; Tramadol /acetaminophen;   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   13件:
3,
6,
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271
 11   Acetate  81件: Acetate; Leuprorelin acetate; 40 mg glatiramer acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Flecainide acetate; Oxaloacetate (oaa); Ulipristal acetate; 11c-acetate; 20mg/0.5ml glatiramer acetate; Bazedoxifene acetate; Cyclophosphamide/glatiramer acetate; Dirucotide acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Nomegestrol acetate; Plovamer acetate; Prednisone acetate; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Tocopherol acetate; Depot leuprolide acetate 3.75 mg; Caspofungin acetate; Desmopressin acetate; Lanreotide acetate; Abiraterone acetate; Gonadorelin acetate and triptorelin acetate; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate 3.75mg injection; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol acetate; Megestrol acetate tablet; Triptorelin acetate and gonadorelin acetate; Macimorelin acetate; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Hydrocortisone sodium acetate; Sodium acetate; Tetracosactide acetate; 11c acetate; Dichloroacetate; Dichloroacetate sodium; Zuretinol acetate; Etiprednol dicloacetate; Delmitide acetate; L-lysyl-d-prolyl-l-threonine acetate; Sotrastaurin (inn) acetate; Cosyntropin acetate; Tetracosactide hexaacetate; Glatiramer acetate (copaxone®); Zinc acetate; Zinc acetate dihydrate; Tocopheryl acetate; Prednisolone acetate; Prednisone acetate tablets; Desmopressin acetate trihydrate; Phosphate and betamethasone acetate, 2 ml.; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; Loestrin (norethindrone acetate and ethinyl estradiol); Zinc acetate (20mg/d);   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299
 12   Acetylsalicylic acid  2件: Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,;   D00109   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231
 13   Activated charcoal  0件:   D03251   -   -   8件:
6,
13,
46,
85,
86,
96,
97,
298
 14   Acyclovir  1件: Acyclovir;   D00222   -   -   5件:
13,
28,
46,
53,
60
 15   Adalimumab  51件: Adalimumab; Adalimumab injection [humira]; Adalimumab (ada); Adalimumab (humira); Adalimumab (humira®); Adalimumab (up to 9 months exposure); Adalimumab 40 mg; Adalimumab 40 mg subcutaneous (sc) every other week (eow); Adalimumab 40mg q2w; Adalimumab 80 mg; Adalimumab pfs and pen; Adalimumab with methotrexate; Adalimumab-eu; Adalimumab-pfizer; Anti-tnf therapy (etanercept or adalimumab); Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Biosimilar product to adalimumab; Double-blind adalimumab; Etanercept or adalimumab; Humira (adalimumab); Humira 40mg solution for injection in pre-filled syringe (adalimumab); Humira® (adalimumab); Infliximab, etanercept, adalimumab; Methotrexate,adalimumab; New formulation adalimumab; Open-label adalimumab; Open-labeladalimumabrescue; Sb5 (proposed biosimilar to adalimumab); Tnf blockers (infliximab, adalimumab, etanercept); Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Adalimumab (40 mg); Adalimumab (d2e7); Adalimumab 40 mg eow or ew; Adalimumab and infliximab; Adalimumab injection; Adalimumab prn; Anti-tnf:adalimumab (subcutaneus); Application of adalimumab; Azathioprine or adalimumab and infliximab; Db adalimumab 40 mg eow; Db adalimumab 40 mg ew; Fitc-adalimumab; Infliximab and adalimumab; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Infliximab, adalimumab, certolizumab pegol; Ol adalimumab 40 mg; Start adalimumab in monotherapy; Treatment with adalimumab; Adalimumab 40 mg sc every other week; Adalimumab, etanercept, golimumab or infliximab; Gp2017 (adalimumab biosimilar);   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271
 16   Adefovir  1件: Adefovir;   D02768   -   -   1件:
46
 17   Ademetionine  0件:   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172
 18   Adenine  0件:   D00034   -   -   1件:
46
 19   Adenosine  6件: 2-cda, 2-chloro-2’-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2’-deoxy-ß-d-adenosine; 2-chloro-2'-deoxyadenosine, 2cda; 2-chloro-2’-deoxyadenosine (2-cda); Adenosine; Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv);   D00045   4件: ADORA1, ADORA2A, ADORA2B, ADORA3   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   5件:
13,
46,
53,
58,
65
 20   Alemtuzumab  18件: Alemtuzumab; Alemtuzumab (gz402673); Alemtuzumab 12 mg; Alemtuzumab 24 mg; Alemtuzumab gz402673; Alemtuzumab immunotherapy; Alemtuzumab injection [lemtrada]; Alemtuzumab (campath); Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994); Alemtuzumab (campath ); Alemtuzumab and rituximab; Alemtuzumab, rituximab; Alemtuzumab 0.2 mg; Alemtuzumab 0.3 mg; Filgrastim, alemtuzumab; Transplant conditioning with mobilization and alemtuzumab; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan;   D02802   -   -   17件:
13,
15,
19,
20,
46,
49,
51,
60,
63,
65,
85,
96,
164,
234,
284,
285,
326
 21   Alendronic acid  1件: Alendronic acid;   D00939
 D07119 
 1件: FDPS   1件: Terpenoid backbone biosynthesis   7件:
19,
41,
46,
50,
271,
274,
299
 22   Alfacalcidol  3件: Alendronate versus alfacalcidol (1-alpha oh vitamin d); Alfacalcidol; Ibandronate+alfacalcidol+calcium;   D01518   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   6件:
41,
46,
49,
50,
96,
235
 23   Alkaline Phosphatase  6件: Alkaline phosphatase; Bovine intesastinal alkaline phosphatase (biap); Bovine intestinal alkaline phosphatase (biap); Bovine-calf alkaline phosphatase (biap); Bovine-calf alkaline phosphatase biap; Human recombinant tissue non-specific alkaline phosphatase fusion protein;   -   -   -   3件:
46,
97,
172
 24   Allopurinol  4件: Allopurinol; Allopurinol sandoz 100 mg, tabletten; Allopurinol sodium; Azathioprine and allopurinol;   D00224   1件: XDH   2件: Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97
 25   Alpha-Linolenic Acid  0件:   -   -   -   1件:
46
 26   Aluminium  3件: Aluminium; Aluminium phosphate; Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate;   -   -   -   1件:
46
 27   Aluminium phosphate  2件: Aluminium phosphate; Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate;   -   -   -   1件:
46
 28   Aminopterin  3件: Aminopterin; Ld-aminopterin; Methylaminopterin;   D02527   -   -   1件:
46
 29   Amoxapine  2件: Amoxapine; Amoxapine & dipyridamole;   D00228   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
46
 30   Amoxicillin  7件: Amoxicillin; Clartihromycin, amoxicillin, and omeprazole; Amoxicillin hydrate; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); Amoxicillin and tetracycline; Amoxicillin, metronidazole and tetracycline; Lansoprazole, amoxicillin, clarithromycin;   D00229
 D02925
 D07452 
 -   -   6件:
6,
46,
63,
96,
97,
222
 31   Anakinra  8件: Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra and peg stnf-r1; Kineret® (anakinra); Response to anakinra associated with methotrexate; Anakinra / kineret; Kineret® or anakinra;   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   17件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
65,
84,
86,
106,
107,
266,
299
 32   Angiotensin II  2件: Angiotensin ii; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin);   D00150
 D02014 
 2件: AGTR1, AGTR2   6件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction   7件:
17,
19,
46,
66,
86,
222,
224
 33   Anifrolumab  4件: Anifrolumab; Anifrolumab (medi-546); Anifrolumab 1000 mg; Anifrolumab 300 mg;   D11082   2件: IFNAR1, IFNAR2   1件: Cytokine-cytokine receptor interaction   2件:
46,
49
 34   Apremilast  7件: Apremilast; Apremilast 20 mg; Apremilast 30 mg; Apremilast 30mg; Apremilast (cc-10004); Apremilast tablet 20 mg; Apremilast tablet 30 mg bid;   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   2件: Purine metabolism, cAMP signaling pathway   5件:
46,
50,
56,
97,
271
 35   Atacicept  8件: Atacicept; Atacicept 150 mg; Atacicept 25 mg; Atacicept 75 mg; Atacicept 75 milligram (mg); Atacicept150mg; Atacicept25mg; Atacicept75mg;   D09704   2件: TNFSF13, TNFSF13B   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   4件:
13,
46,
49,
66
 36   Atorvastatin  9件: Atorvastatin; Interferon beta treatment to add-on atorvastatin treatment; Interferon beta-1b/atorvastatin group; Untreated to atorvastatin treatment; Atorvastatin tablet 20 mg; Atorvastatin 10mg; Atorvastatin 20mg; Lisinopril, losartan, and atorvastatin; Atorvastatin calcium;   D00258
 D00887
 D07474 
 1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299
 37   Azathioprine  33件: Azathioprine; Prednisone - azathioprine; Azathioprine (aza); Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Corticosteroid and azathioprine; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Azathioprine 25 mg; Continuation of azathioprine; Cyclophosphamide-prednisone-azathioprine; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Rituximab (rtx) and azathioprine (aza); Steroids plus azathioprine; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine in case of endoscopic recurrence; Azathioprine individualised dose; Azathioprine or 6-mercaptopurine; Azathioprine or adalimumab and infliximab; Azathioprine or mesalazine; Azathioprine or methotrexate; Azathioprine weight-based dose; Azathioprine+enteral nutrition; Early immunosuppressants (azathioprine, methotrexate); Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, azathioprine; Azathioprine and allopurinol; Overencapsulated azathioprine (imuran) 50 mg tablet; Products containing azathioprine or 6-mercaptopurine; Azathioprine or mycophenolate mofetil;   D00238
 D03033 
 -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162
 38   BMS-582949  2件: Bms-582949; Bms-582949 and methotrexate;   -   -   -   1件:
46
 39   BMS-817399  1件: Bms-817399;   -   -   -   1件:
46
 40   BMS-986104  1件: Bms-986104;   -   -   -   1件:
46
 41   BMS-986142  5件: Bms-986142; Bms-986142 200mg; Bms-986142 350mg; Methotrexate, leucovorin and bms-986142; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142;   -   -   -   2件:
46,
53
 42   Baminercept  3件: Baminercept; Baminercept alfa; Baminercept alfa (bg9924);   D08866   1件: LTB   3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
53,
97
 43   Baricitinib  3件: Baricitinib; Baricitinib, olumiant®; Tofacitinib/baricitinib;   D10308   2件: JAK1, JAK2   3件: Chemokine signaling pathway, JAK-STAT signaling pathway, Osteoclast differentiation   8件:
41,
46,
49,
50,
93,
107,
265,
325
 44   Belatacept  1件: Belatacept;   D03222   2件: CD80, CD86   3件: Allograft rejection, Cell adhesion molecules (CAMs), Intestinal immune network for IgA production   1件:
46
 45   Belimumab  21件: Belimumab; Benlysta (belimumab); Benlysta® (belimumab); Belimumab 10 mg/kg; Belimumab 1 mg/kg; Belimumab 4 mg/kg; Belimumab 10 mg/kg plus standard therapy; Belimumab 100 mg sc; Belimumab 10mg/kg; Belimumab 200 mg sc; Belimumab 200 mg/ml; Belimumab for iv; Belimumab for sc; Belimumab injection; Belimumab or benlysta; Belimumab plus early vaccination; Belimumab plus late vaccination; Benlysta™ (belimumab); Sc belimumab 200 mg; Belimumab 10 mg; Gsk1550188 (belimumab);   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   8件:
11,
43,
44,
46,
49,
51,
53,
222
 46   Benzimidazole  2件: Benzimidazole; Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 h-benzimidazole;   -   -   -   1件:
46
 47   Benzyl alcohol  0件:   D00077   -   -   3件:
28,
46,
271
 48   Betamethasone  6件: Betamethasone; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Betamethasone acibutate; Intra-articular compound betamethasone; Intraarticular betamethasone; Phosphate and betamethasone acetate, 2 ml.;   D00244
 D00972
 D01357
 D01402
 D01637
 D02032
 D02286 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   6件:
2,
46,
65,
90,
96,
235
 49   Bifenthrin  0件:   -   -   -   2件:
6,
46
 50   Bimekizumab  1件: Bimekizumab;   D11550   2件: IL17A, IL17F   2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway   3件:
46,
97,
271
 51   Binetrakin  0件:   D03117   -   -   1件:
46
 52   Bortezomib  6件: Bortezomib; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Combination of a single dose anti-cd20 antibody and bortezomib; Bortezomib (velcade®);   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331
 53   Branebrutinib  0件:   D11478   1件: BTK   3件: B cell receptor signaling pathway, NF-kappa B signaling pathway, Platelet activation   1件:
46
 54   Bucillamine  2件: Bucillamine; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin);   D01809   -   -   1件:
46
 55   Bupivacaine  9件: Bupivacaine; Bupivacaine hydrochloride; Levobupivacaine; Liposomal bupivacaine; Bupivacaine/epinephrine/dexamethasone; Lap tap bupivacaine/epinephrine; Us tap bupivacaine/epinephrine; Bupivacaine injection 0.5%; Bupivacaine & triamcinolone acetonide;   D01450
 D07552 
 1件: SCN1A   1件: Dopaminergic synapse   7件:
46,
53,
70,
96,
168,
226,
298
 56   Buprenorphine  2件: Buprenorphine; Buprenorphine transdermal patch;   D00836
 D07132 
 2件: OPRK1, OPRM1   1件: Neuroactive ligand-receptor interaction   2件:
46,
70
 57   CCX-354  0件:   -   -   -   1件:
46
 58   CRx-139  1件: Crx-139;   -   -   -   1件:
46
 59   Caffeine  5件: Caffeine; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Caffeine 100 mg;   D00528
 D01453 
 9件: ADORA1, ADORA2A, PDE1B, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway   6件:
2,
6,
46,
78,
96,
97
 60   Calcitriol  4件: Calcitriol; Delayed release 6mp or calcitriol vs. purinethol; Rapamycin-calcitriol combination; Calcitriol & calcium;   D00129   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   8件:
37,
46,
49,
66,
96,
158,
235,
326
 61   Calcium  26件: Calcium; Calcium carbonate; Calcium levofolinate; Ascal(r) / carbasalate calcium; Calcium and cholecalciferol; Calcium citrate; Carbasalate calcium; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Rosuvastatin calcium; Calcium channel blockers; Calcium channel blockers (amlodipine, azelnidipine); Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Calcium citrate with vitamin d2; Vidofludimus calcium; Calcium gluconate; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Low molecular weight heparin calcium injection; Amorphous calcium carbonate; Calcitriol & calcium; Calcium carbonate and alphacalcidol; Calcium lactate; Crystalline calcium supplements; Atorvastatin calcium; Calcium, dietary;   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299
 62   Calcium Carbonate  3件: Calcium carbonate; Amorphous calcium carbonate; Calcium carbonate and alphacalcidol;   D00932
 D10802 
 -   -   7件:
13,
19,
46,
75,
96,
235,
299
 63   Calcium Citrate  2件: Calcium citrate; Calcium citrate with vitamin d2;   D00933   -   -   3件:
46,
84,
235
 64   Canakinumab  7件: Canakinumab; Canakinumab (investigational); Canakinumab (proposed); Canakinumab (acz885); Canakinumab (company code: acz885d); Canakinumab (who approval pending); Canakinumab injection [ilaris];   D09315   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   9件:
46,
56,
84,
106,
107,
108,
113,
266,
269
 65   Cannabidiol  6件: Cannabidiol; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol capsule 5 mg; Cannabidiol tablet 10 mg; Cannabidiol (cbd); Cannabidiol oral solution;   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   14件:
2,
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271
 66   Carbaspirin calcium  0件:   D03385   -   -   1件:
46
 67   Carbonate ion  0件:   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299
 68   Celecoxib  7件: Celecoxib; Fixed dose combination ciprofloxacin/celecoxib; Celecoxib (celebrex); Celecoxib 200mg capsule; Celecoxib 200 milligrams; Celecoxib 400 milligrams; Celecoxib, celebrex®;   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   9件:
2,
3,
34,
46,
70,
89,
96,
161,
271
 69   Certolizumab pegol  11件: Certolizumab pegol; 99mtc-s-hynic certolizumab pegol; Certolizumab pegol (cdp870, tradename cimzia); Certolizumab pegol (cdp870, tradename cimzia)(prefilled syringes at the dose of 200mg); Certolizumab pegol (czp); Certolizumab pegol + methotrexate (mtx); Certolizumab pegol (cdp870); Certolizumab pegol (rinn); Certolizumab pegol 400 mg; Infliximab, adalimumab, certolizumab pegol; Cimzia certolizumab pegol 200 mg/ml solution for injection;   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   6件:
37,
46,
96,
97,
226,
271
 70   Cetrorelix  1件: Cetrorelix;   D01685
 D07665 
 1件: GNRHR   2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction   1件:
46
 71   Chicken  2件: Chicken; Chicken type ii collagen;   -   -   -   1件:
46
 72   Chloride ion  0件:   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299
 73   Chlorine  0件:   -   -   -   2件:
46,
271
 74   Chloroquine  14件: Chloroquine; Hydroxychloroquine; Hydroxychloroquine sulfate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Sulphasalazine + hydroxychloroquine or prednisolone; Hydroxychloroquine (z0188); Hydroxychloroquine high; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Versus hydroxychloroquine; Chloroquine diphosphate; Chloroquine diphosphate 250mg;   D02125
 D02366
 D03469 
 -   -   4件:
46,
49,
95,
130
 75   Chloroxylenol  0件:   D03473   -   -   4件:
6,
13,
46,
168
 76   Cholecalciferol  9件: Cholecalciferol; Cholecalciferol, vitamin d3; Calcium and cholecalciferol; Cholecalciferol and c. xanthorrhiza; Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol concentrate; 5000 iu of cholecalciferol; Cholecalciferol (vitamin d3);   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   15件:
6,
13,
19,
20,
34,
46,
49,
53,
60,
65,
96,
97,
228,
298,
299
 77   Chromic chloride  0件:   D03479   -   -   1件:
46
 78   Chromium  1件: Chromium;   -   -   -   1件:
46
 79   Ciclosporin  7件: Ciclosporin; Ciclosporina; Ciclosporine; Aerolised liposomal ciclosporin a; Ciclosporin (ciclosporinium); Ciclosporin a; Ciclosporine, ciclosporina;   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   44件:
11,
14,
19,
20,
26,
28,
36,
38,
39,
40,
41,
42,
45,
46,
49,
50,
53,
55,
56,
58,
60,
61,
62,
63,
64,
65,
90,
95,
97,
113,
162,
164,
222,
223,
226,
228,
234,
269,
274,
283,
284,
285,
302,
326
 80   Citalopram  2件: 20mg daily citalopram; Citalopram;   D00822
 D07704 
 1件: SLC6A4   1件: Serotonergic synapse   3件:
8,
46,
127
 81   Citric acid  3件: Citric acid; Citric acid based mouthwash; Sodium picosulfate, magnesium oxide and citric acid;   D00037
 D01222 
 -   -   4件:
46,
53,
245,
291
 82   Clazakizumab  1件: Clazakizumab;   D10312   -   -   2件:
46,
96
 83   Clindamycin  1件: Clindamycin;   D00277
 D01073
 D01990
 D02132 
 -   -   1件:
46
 84   Clofarabine  2件: Clofarabine; Campath, busulfan, clofarabine;   D03546   3件: POLA1, POLA2, RRM1   3件: DNA replication, Purine metabolism, Pyrimidine metabolism   9件:
19,
20,
40,
46,
49,
60,
96,
234,
326
 85   Cobalt  1件: Cobalt;   -   -   -   1件:
46
 86   Cobiprostone  1件: Cobiprostone;   D08893   -   -   1件:
46
 87   Cod liver oil  1件: Cod liver oil;   D03578   -   -   1件:
46
 88   Corn  3件: Corn; Corn oil capsules; Corn/soy oil;   -   -   -   2件:
46,
240
 89   Corticotropin  10件: Corticotropin; Repository corticotropin injection; H.p. acthar gel (repository corticotropin injection); H.p. acthar® gel (repository corticotropin injection); Corticotropin-releasing hormone; Ovine corticotropin-releasing hormone (ocrh); Corticotropin releasing hormone; Repository corticotropin injection -treatment extension; Adrenocorticotropin; Adrenocorticotropin hormone;   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   12件:
2,
13,
46,
49,
50,
66,
75,
78,
84,
145,
193,
222
 90   Creatine  4件: Creatine; Creatine monohydrate; Pyruvate, creatine, niacinamide; Creatine-13c;   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201
 91   Creatinine  1件: Creatinine;   D03600   -   -   3件:
2,
46,
60
 92   Curcumin  6件: Curcumin; Ifn beta 1 a + curcumin (bcm 95); Nanocurcumin; Curcumin (longvida™); Curcumin supplement; Bio-enhanced curcumin soft gelatin capsule;   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299
 93   Cyclophosphamide  49件: Cyclophosphamide; Cyclophosphamide (drug); Cyclophosphamide and atg; Cyclophosphamide monohydrate; Cyclophosphamide/glatiramer acetate; Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Lenalidomide, dexamethasone and cyclophosphamide; Rituximab and cyclophosphamide iv; Prednisone, cyclophosphamide; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Cyclophosphamide-prednisone-azathioprine; Iv cyclophosphamide; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Cyclophosphamide (cy); Cyclophosphamide (cy) (plan 1); Cyclophosphamide (cy) (plan 2); Cyclophosphamide 100mg; Cyclophosphamide 150mg; Cyclophosphamide 50mg; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Cyclophosphamide,campath ih and tbi; Cyclophosphamide,cyclosporine a; Fludarabine, cyclophosphamide; Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide''; Busulfan, cyclophosphamide, atg, gcsf; Campath, fludarabine, cyclophosphamide; Cyclophosphamide 30; Cyclophosphamide 40; Cyclophosphamide dose level 1; Cyclophosphamide dose level 2; Cyclophosphamide dose level 3; Cyclophosphamide dose level 4; Cyclophosphamide post transplant; Prednisone and cyclophosphamide; Prednisone plus cyclophosphamide; High-dose cyclophosphamide; Cyclophosphamide 50mg oral tablet; Cyclophosphamide and steroids; Cyclophosphamide(ctx); Cyclophosphamide + pred; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Thalidomide, cyclophosphamide and prednisone;   D00287
 D07760 
 -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331
 94   Denosumab  4件: Denosumab; Pralia 60 mg subcutaneous injection syringe(denosumab); Pralia 60mg subcutaneous injection syringe(denosumab); Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand;   D03684   1件: TNFSF11   2件: Cytokine-cytokine receptor interaction, Osteoclast differentiation   7件:
46,
50,
93,
95,
96,
274,
299
 95   Dexamethasone  35件: Dexamethasone; Dexamethasone soduim phosphate; Lenalidomide and dexamethasone; Lenalidomide+dexamethasone; Lenalidomide, dexamethasone; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Dexamethasone, 40 mg; Lenalidomide, dexamethasone and cyclophosphamide; Melphalan, thalidomide and dexamethasone; Pomalidomide and dexamethasone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Dexamethasone (50mg 1dd6, 3 consecutive days/month); Control intervention (no dexamethasone); Intraarticular dexamethasone; Intravenous dexamethasone 1 mg; Peri-neural dexamethasone 1 mg; Dexamethasone parotid irrigation; Dexamethasone (1 cycle); Dexamethasone (4 cycles); Dexamethasone abcur; Dexamethasone and rituximab; High dose dexamethasone pulses; Dexamethasone sodium phosphate; Dexamethasone sodium phosphate ph. eur.; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Dexamethasone 0.5mg tablet; Dexamethasone 2mg tablets; Dexamethasone 0,5mg; Bupivacaine/epinephrine/dexamethasone; Dexamethasone sodium phosphate 250 mg/ 10 ml; Dexamethasone 21-phosphate; Mmf and dexamethasone; Dexamethasone sodium phosphate 250 mg/10 ml solution;   D00292
 D00975
 D01510
 D01615
 D01632
 D01948
 D02174
 D02591
 D02592 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299
 96   Dextromethorphan  9件: Dextromethorphan; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; Dextromethorphan hydrobromide; Dextromethorphan and caffeine; Dextromethorphan 30 mg;   D00848
 D03742
 D03744 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156
 97   Diacerein  4件: Ccp-020 (diacerein 1% ointment); Diacerein; Diacerein 1% ointment; Diacerein 1% ointment topical formulation;   D07270   -   -   2件:
36,
46
 98   Diazepam  2件: Diazepam; Diazepam, melatonin;   D00293   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   3件:
46,
155,
298
 99   Diclofenac  9件: Diclofenac; Diclofenac sodium topical gel; Diclofenac sodium; Comparator: diclofenac; Comparator: diclofenac sodium; Diclofenac + omeprazole; Diclofenac natrium pch retard tablet mga 75mg; Diclofenac 50 milligrams; Diclofenac sr;   D00903
 D00904
 D07816 
 2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   4件:
13,
34,
46,
271
 100   Digoxin  3件: Digoxin; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142;   D00298   4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4   2件: Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction   2件:
8,
46
 101   Dimethyl fumarate  4件: Dimethyl fumarate; Dimethyl fumarate (dmf); Dimethyl fumarate [dmf]; Tecifdera (dimethyl fumarate);   D03846   -   -   5件:
13,
46,
49,
51,
86
 102   Dipyridamole  7件: Amoxapine & dipyridamole; Dipyridamole; Prednisolone & dipyridamole; Prednisolone-dipyridamole; Z102 (prednisolone and dipyridamole).; Extended release dipyridamole 200mg/aspirin 25mg; Dipyridamole tab 25 mg;   D00302   2件: PDE4A, PDE5A   2件: cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
46,
49,
51,
66,
224
 103   Donepezil  4件: Donepezil; Donepezil sandoz; Donepezil hci (drug); Donepezil hydrochloride;   D00670
 D07869 
 1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   9件:
5,
6,
13,
46,
78,
124,
127,
156,
206
 104   Doxycycline  7件: Doxycycline; Interferon beta 1a, oral doxycycline; Doxycycline hyclate; Antimicrobial therapy: co-trimoxazole or doxycycline; Doxycycline 100 mg capsules; Treatment with systemic therapy (doxycycline); Doxycycline hyclate ph.eur;   D00307
 D02129
 D03903
 D03904
 D07876 
 -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299
 105   Dronabinol  4件: Dronabinol; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Dronabinol capsule 2,5 mg; Dronabinol capsule 2.5. mg;   D00306   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   5件:
2,
13,
46,
271,
298
 106   Edoxaban  1件: Edoxaban;   D09546
 D09710 
 1件: F10   1件: Complement and coagulation cascades   2件:
46,
88
 107   Efalizumab  1件: Efalizumab;   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   9件:
11,
13,
37,
46,
49,
53,
61,
95,
96
 108   Eldecalcitol  1件: Eldecalcitol;   D07578   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   1件:
46
 109   Enalapril  4件: Enalapril; Enalapril and other angiotensin converting enzyme inhibitors; Enalapril maleate; Enalapril valsartan methylprednisone;   D00621
 D07892 
 1件: ACE   1件: Renin-angiotensin system   4件:
19,
46,
66,
113
 110   Enoxaparin  1件: Enoxaparin;   D03674
 D07510 
 1件: SERPINC1   1件: Complement and coagulation cascades   1件:
46
 111   Entecavir  1件: Entecavir;   D04008
 D07896 
 -   -   5件:
46,
56,
96,
97,
271
 112   Epinephrine  4件: Epinephrine; Bupivacaine/epinephrine/dexamethasone; Lap tap bupivacaine/epinephrine; Us tap bupivacaine/epinephrine;   D00095
 D00996
 D02149 
 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   9件:
6,
13,
46,
86,
96,
168,
226,
231,
256
 113   Ergocalciferol  2件: Ergocalciferol; Ergocalciferol (vitamin d2);   D00187   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   5件:
46,
84,
96,
97,
299
 114   Erythropoietin  4件: Erythropoietin; Recombinant human erythropoietin(rhepo); Erythropoietin human recombinant (eporh); Recombinant human erythropoietin;   D03231   1件: EPOR   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   9件:
2,
6,
13,
22,
46,
47,
70,
95,
96
 115   Esomeprazole  3件: Esomeprazole; Esomeprazole 20 mg; Nexium (esomeprazole magnesium);   D01984
 D04056
 D07917
 D09339 
 2件: ATP4A, ATP4B   3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation   6件:
6,
46,
86,
98,
298,
299
 116   Estradiol  9件: Estradiol; Estradiol hemihydrate; Ethinylestradiol; Ethinyl estradiol; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); 5% lidocaine/5 mg/ml estradiol compound cream; Estradiol 2 mg; Loestrin (norethindrone acetate and ethinyl estradiol); Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg;   D00105
 D01413
 D01617
 D01953
 D04061
 D04063
 D04064
 D04065 
 2件: ESR1, ESR2   2件: Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway   5件:
13,
46,
49,
226,
299
 117   Eszopiclone  1件: Eszopiclone;   D02624   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   3件:
6,
13,
46
 118   Etanercept  39件: Etanercept; Enbrel (etanercept); Etanercept 50 mg solution for injection; 50 mg etanercept; Anti-tnf therapy (etanercept or adalimumab); Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Commercial formulation etanercept; Etanercept (enbrel); Etanercept (enbreltm); Etanercept + methotrexate; Etanercept , methotrexate; Etanercept / autoinjector a; Etanercept 50mg; Etanercept biosimilar; Etanercept liquid; Etanercept or adalimumab; Etanercept pre-filled syringe sq injection; Etanercept treatment; Etanercept via autoinjector a; Etanercept via autoinjector b; Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), etc; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Methotrexate - etanercept - prednisolone arm; New formulation etanercept; Phase 1: etanercept; Reumatocept (etanercept); Sb4 (etanercept biosimilar); Sb4 (proposed biosimilar to etanercept); Tnf blockers (infliximab, adalimumab, etanercept); Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Etanercept, methotrexate, prednisolone; Adalimumab, etanercept, golimumab or infliximab; Etanercept (50mg per week); Etanercept (50mg per week, for 2 weeks); Etanercept (50mg per week, for 4 weeks); Etanercept (full-dose); Etanercept (half-dose); Tapering or discontinuation of etanercept;   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
15,
28,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298
 119   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 120   Ethinylestradiol  1件: Ethinylestradiol;   D00554   1件: ESR1   3件: Breast cancer, Estrogen signaling pathway, Pathways in cancer   4件:
13,
46,
49,
299
 121   Etodolac  2件: Etodolac; Other non steroidal anti-inflammatory drugs (nsaids) except etodolac;   D00315   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
46
 122   Etoricoxib  6件: Etoricoxib; Mk0663, etoricoxib; Part i - etoricoxib 60 mg; Part i - etoricoxib 90 mg; Part ii- etoricoxib 60 mg; Part ii- etoricoxib 90 mg;   D03710   1件: PTGS2   1件: Arachidonic acid metabolism   2件:
46,
271
 123   Evobrutinib  2件: Evobrutinib; M2951 (other name: evobrutinib);   -   -   -   3件:
13,
46,
49
 124   Famotidine  2件: Famotidine; Famotidine 20 mg;   D00318   1件: HRH2   3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   3件:
6,
46,
86
 125   Fentanyl  5件: Fentanyl; Fentanyl transdermal patch; Transdermal fentanyl matrix, gabapentin; Fentanyl citrate; Dexmedetomidine and fentanyl;   D00320
 D01399 
 1件: OPRM1   1件: Neuroactive ligand-receptor interaction   5件:
46,
70,
85,
215,
231
 126   Filgotinib  4件: Filgotinib; Inn - filgotinib; Proposed inn - filgotinib; Propsoed inn - filgotinib;   D10871   1件: JAK1   3件: JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   6件:
46,
53,
96,
97,
222,
271
 127   Filgrastim  7件: Filgrastim; Pegfilgrastim; Ep2006 (filgrastim); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Filgrastim (g-csf);   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   28件:
2,
6,
13,
16,
25,
26,
28,
34,
35,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
85,
96,
113,
164,
283,
284,
285,
331
 128   Fish oil  10件: Fish oil; Fish oil concentrate; Fish oil, rich in omega-3-acids; Fish oil,rich in omega 3 acids; Lipoic acid (la) with fish oil and la without fish oil; Combination fish oil and borage seed oil; Fish oil supplement; Fish oil, gamma-linolenic acid; Omega-3 fatty acid fish oil supplement; Combination of fish oil and colesevelam;   -   -   -   7件:
13,
46,
49,
66,
96,
260,
299
 129   Fletikumab  0件:   -   -   -   1件:
46
 130   Florasulam  0件:   -   -   -   1件:
46
 131   Fludarabine  23件: Fludarabine; Fludarabine phosphate; Fludarabine monophosphate; Sq fludarabine; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Fludarabine (flu); Fludarabine, cyclophosphamide; Fludarabine/ melphalan; Fludarabine/busulfan; Busulfan, fludarabine and atg; Busulfan, fludarabine, atg, tli; Campath, fludarabine, cyclophosphamide; Fludarabine phosphate 30 mg; Fludarabine phosphate 40 mg; Fludarabine, busulfan, thymoglobulin; Fludarabine, melphalan, thiotepa; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen);   D01907
 D07966 
 1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326
 132   Fludeoxyglucose F-18  0件:   -   -   -   8件:
6,
13,
34,
46,
53,
84,
127,
300
 133   Fluorine F-18  0件:   D05860   -   -   4件:
40,
46,
49,
96
 134   Flurbiprofen  3件: Flurbiprofen; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142;   D00330
 D01475
 D02290 
 2件: PTGS1, PTGS2   2件: Arachidonic acid metabolism, Serotonergic synapse   2件:
13,
46
 135   Flutriciclamide F-18  0件:   -   -   -   1件:
46
 136   Folic acid  5件: Folic acid; Folic acid, vitamin b6, vitamin b12; Folic acid or folate; Rituximab, mtx, folic acid; Methotrexate and folic acid;   D00070   -   -   11件:
6,
13,
46,
49,
62,
84,
86,
96,
97,
254,
284
 137   Fontolizumab  1件: Fontolizumab;   D04242   1件: IFNG   1件: Cytokine-cytokine receptor interaction   1件:
46
 138   Fostamatinib  9件: Fostamatinib; Fostamatinib 50 mg blue film-coated tablet; Fostamatinib disodium; Fostamatinib disodium (r935788); Fostamatinib 150 mg bid; Fostamatinib 100 mg; Fostamatinib 150 mg; Fostamatinib disodium tablet 100 mg; Fostamatinib disodium tablet 150 mg;   D09347   1件: SYK   2件: B cell receptor signaling pathway, NF-kappa B signaling pathway   4件:
46,
49,
61,
66
 139   GLPG-0259  0件:   -   -   -   1件:
46
 140   GS-5745  3件: Gs-5745; Gs-5745 iv; Gs-5745 sc;   -   -   -   2件:
46,
97
 141   GSK-3117391  0件:   -   -   -   1件:
46
 142   GW-274150  0件:   -   -   -   1件:
46
 143   GW-406381  0件:   -   -   -   1件:
46
 144   Gadobutrol  1件: Gadobutrol;   D07420   -   -   3件:
13,
22,
46
 145   Gadolinium  6件: Gadolinium; Gadolinium-based contrast; Standard gadolinium contrast; Gadolinium contrast; Gadolinium for abdomen; Gadolinium for lower back;   -   -   -   6件:
13,
34,
46,
58,
65,
305
 146   Gamolenic acid  0件:   D07213   -   -   1件:
46
 147   Ginger  1件: Ginger;   D06744   -   -   1件:
46
 148   Ginseng  4件: American ginseng; American ginseng extract ht-1001; Ginseng; Korean red ginseng;   D06772   -   -   3件:
13,
46,
53
 149   Ginsenosides  0件:   -   -   -   1件:
46
 150   Glucosamine  1件: Glucosamine;   D04334   -   -   2件:
46,
271
 151   Gold  3件: Gold; Gold nanocrystals; Sodium aurothiomalate (intramuscular gold);   -   -   -   5件:
2,
6,
13,
46,
171
 152   Golimumab  36件: Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Golimumab; Golimumab 100 mg; Golimumab 100 mg injections; Golimumab 2 mg/kg iv; Golimumab 50 mg; Golimumab 50 mg injections; Golimumab final vialed product (fvp); Golimumab intravenous; Golimumab intravenous (iv); Golimumab liquid in prefilled pen; Golimumab liquid in prefilled syringe; Golimumab liquid in vial; Golimumab pre-filled syringe; Iv golimumab; Sc golimumab; Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Exposure to golimumab; Golimumab (glm); Golimumab (optimization); Golimumab 1 mg per kg; Golimumab 2 mg per kg; Golimumab 200 mg; Golimumab 4 mg per kg; Golimumab 400 mg; Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg; Golimumab dose 1; Golimumab dose 2; Golimumab prefilled syringe; Golimumab treatment optimization.; Simponi (golimumab); Simponi® (golimumab); Adalimumab, etanercept, golimumab or infliximab; Golimumab (cnto 148); Golimumab injection;   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   5件:
46,
84,
96,
97,
271
 153   Grapefruit  2件: Grapefruit; Grapefruit juice;   -   -   -   5件:
6,
46,
50,
83,
97
 154   Green tea leaf  1件: Green tea leaf;   D06903   -   -   5件:
6,
17,
28,
46,
96
 155   HE3286  1件: He3286;   -   -   -   2件:
46,
97
 156   HZT-501  1件: Hzt-501;   -   -   -   1件:
46
 157   Hepatitis A Vaccine  3件: Hepatitis a vaccine; Hepatitis a vaccine and tetanus vaccine; Epaxal berna (virosomal hepatitis a vaccine);   -   -   -   3件:
46,
96,
97
 158   Human interleukin-2  3件: Human interleukin-2; Recombinant human interleukin-2 (rhil-2); Anti-human interleukin-23 monoclonal antibody;   -   -   -   14件:
2,
13,
35,
46,
49,
51,
55,
56,
63,
65,
95,
96,
97,
271
 159   Hyaluronic acid  5件: Hyaluronic acid; Standard care hyaluronic acid eye drops; Hyaluronic acid and chondroitin sulfate; Hyaluronic acid/chondroitin sulfate; Hyaluronic acid inhalation solution;   D08043   -   -   7件:
46,
53,
70,
97,
226,
231,
299
 160   Hydroxide ion  0件:   -   -   -   4件:
46,
96,
97,
284
 161   Hydroxychloroquine  16件: Hydroxychloroquine; Hydroxychloroquine sulfate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Sulphasalazine + hydroxychloroquine or prednisolone; Hydroxychloroquine (z0188); Hydroxychloroquine high; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Versus hydroxychloroquine; Hydroxychloroquine + prednisone; Sirolimus and hydroxychloroquine; Hydroxychloroquine higher dose; Hydroxychloroquine lower dose; Hydroxychloroquine sulphate;   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299
 162   Ibandronate  2件: Ibandronate; Ibandronate+alfacalcidol+calcium;   D08056   1件: FDPS   1件: Terpenoid backbone biosynthesis   2件:
46,
49
 163   Ibuprofen  5件: Ibuprofen; Rebif new formulation + ibuprofen prn; Rebif new formulation + prophylactic ibuprofen; Ibuprofen pch tablet 600mg; Ibuprofen 200mg;   D00126
 D01122
 D04490
 D06606 
 2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   6件:
13,
46,
65,
113,
271,
299
 164   Iguratimod  2件: Iguratimod; Iguratimod (careram);   D01146   1件: NFKB1   2件: NF-kappa B signaling pathway, Osteoclast differentiation   3件:
46,
53,
271
 165   Imatinib  6件: Imatinib; Imatinib mesilate; Imatinib mesylate; Imatinib mesylate (gleevec); Bevacizumab (avastin) and imatinib mesylate (gleevec); Imatinib mesylate 400mg capsule;   D01441
 D08066 
 3件: ABL1, KIT, PDGFRA   3件: Chronic myeloid leukemia, MAPK signaling pathway, Pathways in cancer   11件:
13,
28,
34,
35,
46,
51,
85,
86,
87,
89,
162
 166   Infliximab  66件: Infliximab; Infliximab [infliximab biosimilar 3]; Topical infliximab; Remicaide (infliximab); Abp 710 - biosimilar to infliximab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Biosimilar infliximab; Infliximab (inf) + mtx, db; Infliximab (remicade); Infliximab + methotrexate (mtx); Infliximab 10 mg/kg; Infliximab 3 mg/kg; Infliximab biosimilar; Infliximab control; Infliximab group; Infliximab increased dose; Infliximab increased frequency; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Infliximab, methylprednisolone, methotrexate; Infliximab-eu; Infliximab-pfizer; Innovator infliximab; Methotrexate + infliximab; Remicade (infliximab); Remicade® (infliximab); Remsima (infliximab); Response to infliximab associated with methotrexate; Sb2 (infliximab biosimilar); Sb2 (proposed biosimilar to infliximab); Ta-650 (infliximab); Tnf blockers (infliximab, adalimumab, etanercept); Trexan+salazopyrin+oxiklorin+prednisolone + infliximab; Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Intravitreal infliximab; 99m technetium infliximab; 99mtc-infliximab; Inflectra (infliximab); Adalimumab and infliximab; Anti tnf therapy including infliximab; Anti-tnf: infliximab (infusion); Azathioprine or adalimumab and infliximab; Ct-p13 sc (infliximab); Infliximab (ifx alone); Infliximab (remicade): 100 mg of lyophilized infliximab; Infliximab 20 mg/kg; Infliximab 5 mg/kg; Infliximab 5 mg/kg body weight infused over 2 hours; Infliximab 5 mg/kg every 6 weeks; Infliximab 7 mg/kg every 8 weeks; Infliximab and adalimumab; Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab infusion; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, adalimumab, certolizumab pegol; Infliximab, azathioprine; Infliximab-biosimilar; Infliximab-innovator; Cyclosporine vs infliximab; Infliximab (ifx); Adalimumab, etanercept, golimumab or infliximab; Infliximab (bcd-055); Infliximab and mtx;   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   23件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
85,
95,
96,
97,
98,
162,
164,
269,
271
 167   Interleukin-10  0件:   -   -   -   1件:
46
 168   Iodine  1件: Iodine;   D00108   -   -   3件:
28,
46,
88
 169   Isopropyl alcohol  0件:   D00137   -   -   10件:
13,
46,
58,
84,
96,
97,
269,
271,
279,
298
 170   Itacitinib  1件: Itacitinib;   D10944   1件: JAK1   2件: JAK-STAT signaling pathway, PI3K-Akt signaling pathway   4件:
46,
60,
97,
228
 171   JNJ-40346527  5件: Jnj-40346527; Jnj-40346527-aac - capsule - 50 mg; Jnj-40346527-aac; Prv-6527 (jnj-40346527); Prv-6527(jnj-40346527);   -   -   -   2件:
46,
96
 172   KC706  1件: Kc706;   -   -   -   2件:
35,
46
 173   Ketoprofen  1件: Ketoprofen;   D00132   2件: PTGS1, PTGS